RSK Inhibition in CDK4/CDK6 Resistant ER+ Breast Cancer by Shreya Priyadarshi '24 Department of Pathology, Microbiology, and Immunology Vanderbilt University Medical Center Deborah Lannigan, M.D. Honors STEM